Cargando…
Optimization of Antidepressant use with Pharmacogenetic Strategies
BACKGROUND: The response rate in the pharmacological treatment of depression has been estimated to be around 50%, achieving a remission in symptomatology in only one third of the patients. Suboptimal prescription of antidepressants has been proposed as a significant explanatory factor for this thera...
Autores principales: | Torrellas, Clara, Carril, Juan Carlos, Cacabelos, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635649/ https://www.ncbi.nlm.nih.gov/pubmed/29081699 http://dx.doi.org/10.2174/1389202918666170426164940 |
Ejemplares similares
-
Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2018) -
Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2023) -
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2021) -
Personalized Medicine of Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2014) -
Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
por: Cacabelos, Ramón, et al.
Publicado: (2015)